6,7-Dimethoxyquinoxaline-2,3(1H,4H)-dione, 97.0%, 1g

Cryogenic vials free-standing outer thread, 1.2 ml, Silicone seal, 100 Piece(s)

1,3-Di(2-pyridyl)propane>97.0%(GC)500g

(1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol, 98%, 10mg

3,6-Dichloro-4-methylpyridazine, 97.0%, 10g

2-(4-(Benzyloxy)-2-ethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

2-(3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL)ACETONITRILE, 95.0%, 1g

5-methylsalicylic acid, min. 98%, for synthesis, 25 g, plastic packaging.

2-(methylamino)-3-phenylpropan-1-ol, 95.0%, 1g

4'-(Di-p-tolylamino)-[1,1'-biphenyl]-4-yl Acrylate>97.0%(HPLC)(N)1g

Running module PROclamp MAXI

4-Amino-3-bromo-2-chloropyridine, 95.0%, 25g

3,5-Difluorophenylacetylene, 95.0%, 25g